Want to join the conversation?
Goldman Sachs analyst Joseph Ritchie questions $ROP whether there were any mix issues that impacted 1H16 GM beyond just M&A in the Medical segment. CEO Brian Jellison says that M&A does have impact on GM and the relative mix so far this year is also a contributor. $ROP believes that the remainder of the year is driven more by medical product sales.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.